Summary
This report describes the development and deployment of the COVID-19 Recruitment Data Mart at Vanderbilt Institute for Clinical and Translational Research, an informatics platform designed to rapidly identify eligible research participants for COVID-19 clinical trials. The system combines technological infrastructure with dedicated project management support to facilitate researcher-participant matching against study-specific criteria. Since launch in July 2020, the platform has demonstrated feasibility through four active studies and 1,693 matched participant referrals, suggesting potential scalability for other time-sensitive research recruitment scenarios.
UK applicability
The methodological approach and platform architecture described may be applicable to UK clinical research infrastructure, particularly NHS-based research networks seeking to streamline participant recruitment for acute health crises or time-sensitive studies. However, direct applicability would depend on UK data governance frameworks, NHS trust structures, and existing patient consent registries.
Key measures
Number of studies onboarded (four); total potential participant matches identified (1,693); implementation timeline (launched 20 July 2020)
Outcomes reported
The study reports on the implementation and initial performance of the COVID-19 Recruitment Data Mart platform, which matched 1,693 potential study participants to four onboarded COVID-19 research studies. The platform identified eligible candidates from a pool of patients who had consented to direct contact for COVID-19 research and matched them against study-specific inclusion/exclusion criteria.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.